New test that helps identify HCV in blood receives FDA approval

Roche, a pharmaceutical company, announced that the U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, v2.0.

Advertisement

The test can be used in the detection and identification of HIV, Hepatitis C virus and Hepatitis B virus in human blood. This is the latest version of the cobas TaqScreen MPX Test and it provides increased sensitivity. It uses real-time, multi-dye PCR technology to detect and discriminate for HIV, HCV and HBV.

The test has received the CE Mark and has been approved in Canada, Brazil, China and India.  

More articles on gastroenterology:

Hunterdon Healthcare opens reflux and motility center
Dr. Jennifer Leigh joins Gastroenterology Associates of Manatee
11 GI physicians recently in the news

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.